Sporadic Alzheimer disease fibroblasts display an oxidative stress phenotype

Free Radical Biology and Medicine

Volumn 53, Issue 6, 2012, Pages 1371-1380

  Ramamoorthy, Mahesh ^a,b   Sykora, Peter ^a   Scheibye Knudsen, Morten ^a   Dunn, Christopher ^a   Kasmer, Cindy ^a   Zhang, Yongqing ^a   Becker, Kevin G ^a   Croteau, Deborah L ^a   Bohr, Vilhelm A ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

8 OxoG; Alzheimer disease; Array analysis; Free radicals; Oxidative DNA damage; Oxidative stress

Indexed keywords

HYDROGEN PEROXIDE; MENADIONE;

ALZHEIMER DISEASE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION;

ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CELLS, CULTURED; DNA DAMAGE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; METABOLIC NETWORKS AND PATHWAYS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDANTS; OXIDATIVE STRESS; PHENOTYPE; TRANSCRIPTION, GENETIC; TRANSCRIPTOME; VITAMIN K 3;

EID: 84865404331     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.07.018     Document Type: Article

References (100)

1. 2011 Alzheimer's Disease Facts and Figures.
2. V. Colangelo, J. Schurr, M.J. Ball, R.P. Pelaez, N.G. Bazan, and W.J. Lukiw Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling J. Neurosci. Res 70 2002 462 473
3. C. Czech, G. Tremp, and Pradier L. Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms Prog. Neurobiol 60 2000 363 384
4. D.L. Price, R.E. Tanzi, D.R. Borchelt, and S.S. Sisodia Alzheimer's disease: genetic studies and transgenic models Annu. Rev. Genet. 32 1998 461 493
5. B.S. Shastry Molecular and cell biological aspects of Alzheimer disease J. Hum. Genet. 46 2001 609 618
6. St P.H. George-Hyslop Molecular genetics of Alzheimer's disease Biol. Psychiatry 47 2000 183 199
7. E. Mullaart, M.E. Boerrigter, R. Ravid, D.F. Swaab, and J. Vijg Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients Neurobiol. Aging 11 1990 169 173
8. S.P. Gabbita, M.A. Lovell, and W.R. Markesbery Increased nuclear DNA oxidation in the brain in Alzheimer's disease J. Neurochem. 71 1998 2034 2040
9. L. Lyras, N.J. Cairns, A. Jenner, P. Jenner, and B. Halliwell An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease J. Neurochem 68 1997 2061 2069
10. P. Mecocci, U. MacGarvey, and M.F. Beal Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease Ann. Neurol 36 1994 747 751
11. J. Wang, S. Xiong, C. Xie, W.R. Markesbery, and M.A. Lovell Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease J. Neurochem 93 2005 953 962
12. G. Cohen Oxidative stress, mitochondrial respiration, and Parkinson's disease Ann. N. Y. Acad. Sci. 899 2000 112 120
13. J. Naderi, C. Lopez, and S. Pandey Chronically increased oxidative stress in fibroblasts from Alzheimer's disease patients causes early senescence and renders resistance to apoptosis by oxidative stress Mech. Ageing Dev 127 2006 25 35
14. B. Su, X. Wang, A. Nunomura, P.I. Moreira, H.G. Lee, and G. Perry Oxidative stress signaling in Alzheimer's disease Curr. Alzheimer Res. 5 2008 525 532
15. L. Weissman, N.C. de Souza-Pinto, T. Stevnsner, and V.A. Bohr DNA repair, mitochondria, and neurodegeneration Neuroscience 145 2007 1318 1329
16. A. Ozkul, A. Akyol, C. Yenisey, E. Arpaci, N. Kiylioglu, and C. Tataroglu Oxidative stress in acute ischemic stroke J. Clin. Neurosci. 14 2007 1062 1066
17. M.A. Ansari, and S.W. Scheff Oxidative stress in the progression of Alzheimer disease in the frontal cortex J. Neuropathol. Exp. Neurol. 69 2010 155 167
18. F. Coppede, and L. Migliore DNA damage and repair in Alzheimer's disease Curr. Alzheimer Res 6 2009 36 47
19. G. Gibson, R. Martins, J. Blass, and S. Gandy Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients Life Sci 59 1996 477 489
20. D. Curti, F. Rognoni, L. Gasparini, A. Cattaneo, M. Paolillo, and M. Racchi Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients Neurosci. Lett 236 1997 13 16
21. D.A. Butterfield, and C.M. Lauderback Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress Free Radic. Biol. Med 32 2002 1050 1060
22. M.L. Fishel, M.R. Vasko, and M.R. Kelley DNA repair in neurons: so if they don't divide what's to repair? Mutat. Res 614 2007 24 36
23. L. Weissman, D.G. Jo, M.M. Sorensen, N.C. de Souza-Pinto, W.R. Markesbery, and M.P. Mattson Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment Nucleic Acids Res 35 2007 5545 5555
24. M.A. Lovell, S.P. Gabbita, and W.R. Markesbery Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF J. Neurochem 72 1999 771 776
25. M.A. Lovell, C. Xie, and W.R. Markesbery Decreased base excision repair and increased helicase activity in Alzheimer's disease brain Brain Res 855 2000 116 123
26. C. Shao, S. Xiong, G.M. Li, L. Gu, G. Mao, and W.R. Markesbery Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain Free Radic. Biol. Med 45 2008 813 819
27. E.I. Rogaev, R. Sherrington, C. Wu, G. Levesque, Y. Liang, and E.A. Rogaeva Analysis of the 5′ sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease Genomics 40 1997 415 424
28. W.J. Lukiw, and N.G. Bazan Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex J. Neurosci. Res. 50 1997 937 945
29. N. Chow, C. Cox, L.M. Callahan, J.M. Weimer, L. Guo, and P.D. Coleman Expression profiles of multiple genes in single neurons of Alzheimer's disease Proc. Natl. Acad. Sci. USA 95 1998 9620 9625
30. F.W. van Leeuwen, D.P. de Kleijn, H.H. van den Hurk, A. Neubauer, M.A. Sonnemans, and J.A. Sluijs Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients Science 279 1998 242 247
31. P.J. Yao, R. Morsch, L.M. Callahan, and P.D. Coleman Changes in synaptic expression of clathrin assembly protein AP180 in Alzheimer's disease analysed by immunohistochemistry Neuroscience 94 1999 389 394
32. L.J. Martin Neuronal cell death in nervous system development, disease, and injury Int. J. Mol. Med. 7 2001 455 478
33. K.J. Kyng, A. May, S. Kolvraa, and V.A. Bohr Gene expression profiling in Werner syndrome closely resembles that of normal aging Proc. Natl. Acad. Sci. USA 100 2003 12259 12264
34. V.K. Mootha, C.M. Lindgren, K.F. Eriksson, A. Subramanian, S. Sihag, and J. Lehar PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes Nat. Genet. 34 2003 267 273
35. A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, and M.A. Gillette Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc. Natl. Acad. Sci. USA 102 2005 15545 15550
36. H.M. Huang, R. Martins, S. Gandy, R. Etcheberrigaray, E. Ito, and D.L. Alkon Use of cultured fibroblasts in elucidating the pathophysiology and diagnosis of Alzheimer's disease Ann. N. Y. Acad. Sci. 747 1994 225 244
37. S.Y. Kim, and D.J. Volsky PAGE: parametric analysis of gene set enrichment BMC Bioinformatics 6 2005 144
38. S.H. Schurman, M. Hedayati, Z. Wang, D.K. Singh, E. Speina, and Y. Zhang Direct and indirect roles of RECQL4 in modulating base excision repair capacity Hum. Mol. Genet 18 2009 3470 3483
39. E.M. Blalock, J.W. Geddes, K.C. Chen, N.M. Porter, W.R. Markesbery, and P.W. Landfield Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses Proc. Natl. Acad. Sci. USA 101 2004 2173 2178
40. S.D. Ginsberg, S.E. Hemby, V.M. Lee, J.H. Eberwine, and J.Q. Trojanowski Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons Ann. Neurol. 48 2000 77 87
41. R. Ricciarelli, C. d'Abramo, S. Massone, U. Marinari, M. Pronzato, and M. Tabaton Microarray analysis in Alzheimer's disease and normal aging IUBMB Life 56 2004 349 354
42. G.M. Pasinetti Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia J. Neurosci. Res 65 2001 471 546
43. P.J. Yao, M. Zhu, E.I. Pyun, A.I. Brooks, S. Therianos, and V.E. Meyers Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease Neurobiol. Dis 12 2003 97 109
44. A. Nunomura, G. Perry, M.A. Pappolla, R. Wade, K. Hirai, and S. Chiba RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease J. Neurosci 19 1999 1959 1964
45. P.I. Moreira, S.M. Cardoso, M.S. Santos, and C.R. Oliveira The key role of mitochondria in Alzheimer's disease J. Alzheimers Dis. 9 2006 101 110
46. P.I. Moreira, C. Carvalho, X. Zhu, M.A. Smith, and G. Perry Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology Biochim. Biophys. Acta 2-10 1802 2010
47. P. Coskun, J. Wyrembak, S.E. Schriner, H.W. Chen, C. Marciniack, and F. Laferla A mitochondrial etiology of Alzheimer and Parkinson disease Biochim. Biophys. Acta 553-564 1820 2012
48. I. Rusyn, S. Asakura, B. Pachkowski, B.U. Bradford, M.F. Denissenko, and J.M. Peters Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators Cancer Res 64 2004 1050 1057
49. M. Inoue, G.P. Shen, M.A. Chaudhry, H. Galick, J.O. Blaisdell, and S.S. Wallace Expression of the oxidative base excision repair enzymes is not induced in TK6 human lymphoblastoid cells after low doses of ionizing radiation Radiat. Res 161 2004 409 417
50. K.G. Becker, D.A. Hosack, G. Dennis Jr., R.A. Lempicki, T.J. Bright, and C. Cheadle PubMatrix: a tool for multiplex literature mining BMC Bioinformatics 4 2003 61
51. R.A. Gadient, and U.H. Otten Interleukin-6 (IL-6) - a molecule with both beneficial and destructive potentials Prog. Neurobiol 52 1997 379 390
52. J. Bauer, S. Strauss, U. Schreiter-Gasser, U. Ganter, P. Schlegel, and I. Witt Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices FEBS Lett 285 1991 111 114
53. J. Bauer, U. Ganter, S. Strauss, G. Stadtmuller, U. Frommberger, and H. Bauer The participation of interleukin-6 in the pathogenesis of Alzheimer's disease Res. Immunol 143 1992 650 657
54. U. Ganter, S. Strauss, U. Jonas, A. Weidemann, K. Beyreuther, and B. Volk Alpha 2-macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells: potential significance for the processing of Alzheimer beta-amyloid precursor protein FEBS Lett 282 1991 127 131
55. A. Papassotiropoulos, M. Bagli, F. Jessen, T.A. Bayer, W. Maier, and M.L. Rao A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease Ann. Neurol 45 1999 666 668
56. T.J. Bhojak, S.T. DeKosky, M. Ganguli, and M.I. Kamboh Genetic polymorphisms in the cathepsin D and interleukin-6 genes and the risk of Alzheimer's disease Neurosci. Lett 288 2000 21 24
57. P. Chakrabarty, K. Jansen-West, A. Beccard, and C. Ceballos-Diaz Levites Y., Verbeeck C., et al. Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition FASEB J 24 2010 548 559
58. P.J. McKinnon ATM and the molecular pathogenesis of ataxia telangiectasia Annu. Rev. Pathol 7 2012 303 321
59. K. Savitsky, A. Bar-Shira, S. Gilad, G. Rotman, Y. Ziv, and L. Vanagaite A single ataxia telangiectasia gene with a product similar to PI-3 kinase Science 268 1995 1749 1753
60. A. Barzilai, G. Rotman, and Y. Shiloh ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage DNA Repair (Amsterdam) 1 2002 3 25
61. Z. Guo, S. Kozlov, M.F. Lavin, M.D. Person, and T.T. Paull ATM activation by oxidative stress Science 330 2010 517 521
62. C. Barlow, C. Ribaut-Barassin, T.A. Zwingman, A.J. Pope, K.D. Brown, and J.W. Owens ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation Proc. Natl. Acad. Sci. USA 97 2000 871 876
63. D.G. Hardie AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy Nat. Rev. Mol. Cell Biol. 8 2007 774 785
64. S. Wang, P. Song, and M.H. Zou AMP-activated protein kinase, stress responses and cardiovascular diseases Clin. Sci. (London) 122 2012 555 573
65. T. Sanli, A. Rashid, C. Liu, S. Harding, R.G. Bristow, and J.C. Cutz Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells Int. J. Radiat. Oncol. Biol. Phys. 78 2010 221 229
66. V. Vingtdeux, P. Davies, D.W. Dickson, and P.A.M.P.K. Marambaud is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies Acta Neuropathol 121 2011 337 349
67. B.S. Diniz, and A.L. Teixeira Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond Neuromol. Med. 13 2011 217 222
68. Y. Hu, and Russek S.J. BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation J. Neurochem 105 2008 1 17
69. F. Angelucci, G. Spalletta, I.F. di, A. Ciaramella, F. Salani, and L. Colantoni Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients are characterized by increased BDNF serum levels Curr. Alzheimer Res 7 2010 15 20
70. C. Laske, E. Stransky, T. Leyhe, G.W. Eschweiler, A. Wittorf, and E. Richartz Stage-dependent BDNF serum concentrations in Alzheimer's disease J. Neural Transm. 113 2006 1217 1224
71. J.G. Lee, B.S. Shin, Y.S. You, J.E. Kim, S.W. Yoon, and D.W. Jeon Decreased serum brain-derived neurotrophic factor levels in elderly Koreans with dementia Psychiatry Invest 6 2009 299 305
72. C. Laske, E. Stransky, T. Leyhe, G.W. Eschweiler, W. Maetzler, and A. Wittorf BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls J. Psychiatr. Res. 41 2007 387 394
73. O.V. Forlenza, B.S. Diniz, and W.F. Gattaz Diagnosis and biomarkers of predementia in Alzheimer's disease BMC Med. 8 2010 89
74. S. Kumar, K.F. Harvey, M. Kinoshita, N.G. Copeland, M. Noda, and N.A. Jenkins cDNA cloning, expression analysis, and mapping of the mouse Nedd4 gene Genomics 40 1997 435 443
75. A.B. Fotia, J. Ekberg, D.J. Adams, D.I. Cook, P. Poronnik, and S. Kumar Regulation of neuronal voltage-gated sodium channels by the ubiquitin-protein ligases Nedd4 and Nedd4-2 J. Biol. Chem 279 2004 28930 28935
76. T. Jespersen, M. Membrez, C.S. Nicolas, B. Pitard, O. Staub, and S.P. Olesen The KCNQ1 potassium channel is down-regulated by ubiquitylating enzymes of the Nedd4/Nedd4-like family Cardiovasc. Res 74 2007 64 74
77. E. Kamynina, C. Debonneville, M. Bens, A. Vandewalle, and O. Staub A novel mouse Nedd4 protein suppresses the activity of the epithelial Na channel FASEB J 15 2001 204 214
78. T. Sorkina, M. Miranda, K.R. Dionne, B.R. Hoover, N.R. Zahniser, and A. Sorkin RNA interference screen reveals an essential role of Nedd4-2 in dopamine transporter ubiquitination and endocytosis J. Neurosci 26 2006 8195 8205
79. L.A. Schwarz, B.J. Hall, and G.N. Patrick Activity-dependent ubiquitination of GluA1 mediates a distinct AMPA receptor endocytosis and sorting pathway J. Neurosci 30 2010 16718 16729
80. H. Olzscha, S.M. Schermann, A.C. Woerner, S. Pinkert, M.H. Hecht, and G.G. Tartaglia Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions Cell 144 2011 67 78
81. R. Anindya, O. Aygun, and J.Q. Svejstrup Damage-induced ubiquitylation of human RNA polymerase II by the ubiquitin ligase Nedd4, but not Cockayne syndrome proteins or BRCA1 Mol. Cell 28 2007 386 397
82. K.A. Gallo, and G.L. Johnson Mixed-lineage kinase control of JNK and p38 MAPK pathways Nat. Rev. Mol. Cell Biol. 3 2002 663 672
83. J.J. Yang Mixed lineage kinase ZAK utilizing MKK7 and not MKK4 to activate the c-Jun N-terminal kinase and playing a role in the cell arrest Biochem. Biophys. Res. Commun 297 2002 105 110
84. E. Tosti, L. Waldbaum, G. Warshaw, E.A. Gross, and R. Ruggieri The stress kinase MRK contributes to regulation of DNA damage checkpoints through a p38gamma-independent pathway J. Biol. Chem 279 2004 47652 47660
85. F. Hellborg, W. Qian, C. Mendez-Vidal, C. Asker, M. Kost-Alimova, and M. Wilhelm Human wig-1, a p53 target gene that encodes a growth inhibitory zinc finger protein Oncogene 20 2001 5466 54674
86. S. Varmeh-Ziaie, I. Okan, Y. Wang, K.P. Magnusson, P. Warthoe, and M. Strauss Wig-1, a new p53-induced gene encoding a zinc finger protein Oncogene 15 1997 2699 2704
87. J. Huang, H.B. Wang, L. Yao, X.M. Zheng, and O. Radmark [Dicer interacts with Wig-1 protein] Fen Zi Xi Bao Sheng Wu Xue Bao 41 2008 376 382
88. A. Vilborg, J.A. Glahder, M.T. Wilhelm, C. Bersani, M. Corcoran, and S. Mahmoudi The p53 target Wig-1 regulates p53 mRNA stability through an AU-rich element Proc. Natl. Acad. Sci. USA 106 2009 15756 15761
89. A. Vilborg, C. Bersani, M.T. Wilhelm, and K.G. Wiman The p53 target Wig-1: a regulator of mRNA stability and stem cell fate? Cell Death Differ 18 2011 1434 1440
90. M. Asanuma, I. Miyazaki, Y. Higashi, F.J. Diaz-Corrales, M. Shimizu, and K. Miyoshi Suppression of p53-activated gene, PAG608, attenuates methamphetamine-induced neurotoxicity Neurosci. Lett. 414 2007 263 267
91. F. Gillardon, M. Spranger, C. Tiesler, and K.A. Hossmann Expression of cell death-associated phospho-c-Jun and p53-activated gene 608 in hippocampal CA1 neurons following global ischemia Brain Res. Mol. Brain Res 73 1999 138 143
92. N. Morimoto, M. Nagai, K. Miyazaki, Y. Ohta, T. Kurata, and Y. Takehisa Induction of parkinsonism-related proteins in the spinal motor neurons of transgenic mouse carrying a mutant SOD1 gene J. Neurosci. Res 88 2010 1804 1811
93. M. Shimizu, I. Miyazaki, Y. Higashi, M.J. Eslava-Alva, F.J. Diaz-Corrales, and M. Asanuma Specific induction of PAG608 in cranial and spinal motor neurons of L-DOPA-treated parkinsonian rats Neurosci. Res 60 2008 355 363
94. G. Tomasevic, M. Shamloo, D. Israeli, and T. Wieloch Activation of p53 and its target genes p21(WAF1/Cip1) and PAG608/Wig-1 in ischemic preconditioning Brain Res. Mol. Brain Res 70 1999 304 313
95. J.C. Wang Cellular roles of DNA topoisomerases: a molecular perspective Nat. Rev. Mol. Cell Biol. 3 2002 430 440
96. G. Capranico, S. Tinelli, C.A. Austin, M.L. Fisher, and F. Zunino Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development Biochim. Biophys. Acta 1132 1992 43 48
97. K. Tsutsui, K. Tsutsui, S. Okada, M. Watanabe, T. Shohmori, and S. Seki Molecular cloning of partial cDNAs for rat DNA topoisomerase II isoforms and their differential expression in brain development J. Biol. Chem 268 1993 19076 19083
98. M. Watanabe, K. Tsutsui, K. Tsutsui, and Y. Inoue Differential expressions of the topoisomerase II alpha and II beta mRNAs in developing rat brain Neurosci. Res 19 1994 51 57
99. Y.L. Lyu, and J.C. Wang Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIbeta Proc. Natl. Acad. Sci. USA 100 2003 7123 7128
100. K. Tsutsui, K. Tsutsui, K. Sano, A. Kikuchi, and A. Tokunaga Involvement of DNA topoisomerase IIbeta in neuronal differentiation J. Biol. Chem. 276 2001 5769 5778